4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 250mg

(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>95.0%(HPLC)100mg

4-Bromo-1H-indazole, 95.0%, 5g

2-(4-methylpiperazin-1-yl)ethane-1,1-diol dihydrochloride, 95.0%, 500mg

2-Methoxy-5-(trifluoromethyl)phenylthiourea, 97%, 1g

5-Bromo-2-phenoxypyrimidine, 97.0%, 250mg

3-(4-Bromophenyl)-1H-pyrazole, 96.0%, 10g

tert-Butyl 4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 95.0%, 25g

N-(2-Hydroxyethyl)piperazine-N'-2-hydroxypropanesulfonic acid Hydrate (HEPPSO), 99.0%, 25g

3-Pyridyl Isothiocyanate>98.0%(GC)5g

Methyl 3-bromo-6-methoxypicolinate, 97%, 5g

2,5-Diphenyloxazole [for scintillation spectrometry]>99.0%(HPLC)(N)100g

3-Bromo-5-(trifluoromethyl)benzaldehyde, 97.0%, 25g